{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T01:10:07Z","timestamp":1738631407390,"version":"3.35.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,3]]},"DOI":"10.7759\/cureus.78447","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:40:21Z","timestamp":1738629621000},"source":"Crossref","is-referenced-by-count":0,"title":["Ulcerative Colitis Gone Rogue: A Case of Complement-Mediated Thrombotic Microangiopathy in Inflammatory Bowel Disease"],"prefix":"10.7759","author":[{"given":"Eugene K","family":"Yeboah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aye M","family":"Thida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramtin","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dedipya","family":"Bhamidipati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashil","family":"Dave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Mallapalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2019.388","article-title":"Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome","volume":"35","author":"Lee H","year":"2020","unstructured":"Lee H, Kang E, Kang HG, et al.. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome. Korean J Intern Med. 2020, 35:25-40. 10.3904\/kjim.2019.388","journal-title":"Korean J Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5236.1359","article-title":"Thrombotic microangiopathy presenting as a psychiatric problem","volume":"1","author":"Jones KS","year":"1961","unstructured":"Jones KS, Sim M, Smith WT. Thrombotic microangiopathy presenting as a psychiatric problem. Br Med J. 1961, 1:1359-61. 10.1136\/bmj.1.5236.1359","journal-title":"Br Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake JL","year":"2002","unstructured":"Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002, 347:589-600. 10.1056\/NEJMra020528","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S245642","article-title":"Epidemiology of atypical hemolytic uremic syndrome: a systematic literature review","volume":"12","author":"Yan K","year":"2020","unstructured":"Yan K, Desai K, Gullapalli L, Druyts E, Balijepalli C. Epidemiology of atypical hemolytic uremic syndrome: a systematic literature review. Clin Epidemiol. 2020, 12:295-305. 10.2147\/CLEP.S245642","journal-title":"Clin Epidemiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.12763","article-title":"Atypical hemolytic-uremic syndrome: an update on pathophysiology, diagnosis, and treatment","volume":"23","author":"Raina R","year":"2019","unstructured":"Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, Bagga A. Atypical hemolytic-uremic syndrome: an update on pathophysiology, diagnosis, and treatment. Ther Apher Dial. 2019, 23:4-21. 10.1111\/1744-9987.12763","journal-title":"Ther Apher Dial"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(95)90300-3","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat C","year":"2011","unstructured":"Loirat C, Fremeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011, 6:60. 10.1016\/0046-8177(95)90300-3","journal-title":"Orphanet J Rare Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2017.7053","article-title":"Atypical hemolytic uremic syndrome: a brief review","volume":"9","author":"Zhang K","year":"2017","unstructured":"Zhang K, Lu Y, Harley KT, Tran MH. Atypical hemolytic uremic syndrome: a brief review. Hematol Rep. 2017, 9:7053. 10.4081\/hr.2017.7053","journal-title":"Hematol Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri F","year":"2017","unstructured":"Fakhouri F, Zuber J, Fremeaux-Bacchi V, et al.. Haemolytic uraemic syndrome. Lancet. 2017, 390:681-96. 10.1016\/s0140-6736(17)30062-4","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) Controversies Conference","volume":"91","author":"Goodship TH","year":"2017","unstructured":"Goodship TH, Cook HT, Fakhouri F, et al.. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) Controversies Conference. Kidney Int. 2017, 91:539-51. 10.1016\/j.kint.2016.10.005","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris M","year":"2009","unstructured":"Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009, 361:1676-87. 10.1056\/NEJMra0902814","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2018.07.006","article-title":"Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management","volume":"461","author":"Sridharan M","year":"2018","unstructured":"Sridharan M, Go RS, Willrich MA. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management. J Immunol Methods. 2018, 461:15-22. 10.1016\/j.jim.2018.07.006","journal-title":"J Immunol Methods"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.52547\/ijkd.6916.","article-title":"Difficulties in the differential diagnosis of thrombotic microangiopathy","volume":"1","author":"Sabanis N","year":"2022","unstructured":"Sabanis N, Paschou E, Gavriilaki M. Difficulties in the differential diagnosis of thrombotic microangiopathy. Iran J Kidney Dis. 2022, 1:66-7. 10.52547\/ijkd.6916.","journal-title":"Iran J Kidney Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1306-7","article-title":"Severe atypical HUS caused by CFH S1191L - case presentation and review of treatment options","volume":"25","author":"De S","year":"2010","unstructured":"De S, Waters AM, Segal AO, Trautmann A, Harvey EA, Licht C. Severe atypical HUS caused by CFH S1191L - case presentation and review of treatment options. Pediatr Nephrol. 2010, 25:97-104. 10.1007\/s00467-009-1306-7","journal-title":"Pediatr Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.98","article-title":"Thrombotic microangiopathy: atypical HUS: current diagnostic and therapeutic approaches","volume":"6","author":"Rosales A","year":"2010","unstructured":"Rosales A, Riedl M, Zimmerhackl LB. Thrombotic microangiopathy: atypical HUS: current diagnostic and therapeutic approaches. Nat Rev Nephrol. 2010, 6:504-6. 10.1038\/nrneph.2010.98","journal-title":"Nat Rev Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010111145","article-title":"Targeting complement C5 in atypical hemolytic uremic syndrome","volume":"22","author":"Salant DJ","year":"2011","unstructured":"Salant DJ. Targeting complement C5 in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2011, 22:7-9. 10.1681\/ASN.2010111145","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-019-0207-7","article-title":"Successful use of eculizumab to treat atypical hemolytic uremic syndrome in patients with inflammatory bowel disease","volume":"17","author":"Hanna RM","year":"2019","unstructured":"Hanna RM, Merin N, Burwick RM, et al.. Successful use of eculizumab to treat atypical hemolytic uremic syndrome in patients with inflammatory bowel disease. Thromb J. 2019, 17:18. 10.1186\/s12959-019-0207-7","journal-title":"Thromb J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2014.917574","article-title":"Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab","volume":"36","author":"Green H","year":"2014","unstructured":"Green H, Harari E, Davidovits M, Blickstein D, Grossman A, Gafter U, Gafter-Gvili A. Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab. Ren Fail. 2014, 36:1119-21. 10.3109\/0886022X.2014.917574","journal-title":"Ren Fail"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-019-01052-z","article-title":"Eculizumab treatment of thrombotic microangiopathy in a patient with ulcerative colitis","volume":"13","author":"\u00d8zbay LA","year":"2020","unstructured":"\u00d8zbay LA. Eculizumab treatment of thrombotic microangiopathy in a patient with ulcerative colitis. Clin J Gastroenterol. 2020, 13:344-8. 10.1007\/s12328-019-01052-z","journal-title":"Clin J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.9734\/IJMPCR\/2015\/18771","article-title":"Atypical hemolytic uremic syndrome and chronic ulcerative colitis treated with eculizumab","volume":"4","author":"Webb TN","year":"2015","unstructured":"Webb TN, Griffiths H, Miyashita Y, et al.. Atypical hemolytic uremic syndrome and chronic ulcerative colitis treated with eculizumab. Int J Med Pharm Case Reports. 2015, 4:105-12. 10.9734\/IJMPCR\/2015\/18771","journal-title":"Int J Med Pharm Case Reports"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/333474-ulcerative-colitis-gone-rogue-a-case-of-complement-mediated-thrombotic-microangiopathy-in-inflammatory-bowel-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:40:23Z","timestamp":1738629623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/333474-ulcerative-colitis-gone-rogue-a-case-of-complement-mediated-thrombotic-microangiopathy-in-inflammatory-bowel-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.78447","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,3]]}}}